CHRISTINA FANG: Open Payments
NPI 1003179805 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,311 in 87 payments from 19 companies in 2025. Trend: 2023 $2,698 · 2024 $2,741 · 2025 $2,311
Food & beverage: $2,181Education: $130
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $458 |
| Gilead Sciences, Inc. | 12 | $348 |
| Madrigal Pharmaceuticals | 8 | $275 |
| ABBVIE INC. | 10 | $248 |
| PFIZER INC. | 11 | $205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $116 |
| Lilly USA, LLC | 4 | $113 |
| Aimmune Therapeutics, Inc. | 3 | $76 |
| QOL Medical, LLC | 3 | $72 |
Products named: TREMFYA, REZDIFFRA, Livdelzi, ENTYVIO, LINZESS, VELSIPITY, XIFAXAN, OMVOH.
Industry payments across MD — which companies pay providers there.
